Lin ZZ - Search Results

1

Survival of patients with small cell lung carcinoma in Taiwan.

Kuo YH, Lin ZZ, Yang YY, Shao YY, Shau WY, Kuo RN, Yang JC, Lai MS. Kuo YH, et al. Among authors: lin zz. Oncology. 2012;82(1):19-24. doi: 10.1159/000335084. Epub 2012 Jan 20. Oncology. 2012. PMID: 22269348

2

Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment.

Lin ZZ, Hsu C, Chang YC, Yu CJ, Hsu CH, Lin CC, Cheng AL, Yang PC, Yang CH. Lin ZZ, et al. Among authors: lin cc. Lung Cancer. 2008 May;60(2):215-21. doi: 10.1016/j.lungcan.2007.10.002. Epub 2007 Nov 19. Lung Cancer. 2008. PMID: 18022277 Clinical Trial.

3

Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy.

Yang CH, Yu CJ, Shih JY, Chang YC, Hu FC, Tsai MC, Chen KY, Lin ZZ, Huang CJ, Shun CT, Huang CL, Bean J, Cheng AL, Pao W, Yang PC. Yang CH, et al. Among authors: lin zz. J Clin Oncol. 2008 Jun 1;26(16):2745-53. doi: 10.1200/JCO.2007.15.6695. J Clin Oncol. 2008. PMID: 18509184 Clinical Trial.

4

EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment.

Huang CL, Yang CH, Yeh KH, Hu FC, Chen KY, Shih JY, Lin ZZ, Yu CJ, Cheng AL, Yang PC. Huang CL, et al. Among authors: lin zz. Lung Cancer. 2009 Jun;64(3):346-51. doi: 10.1016/j.lungcan.2008.09.009. Epub 2008 Nov 7. Lung Cancer. 2009. PMID: 18995924

5

Gastric perforation presenting as empyema in a patient with pancreatic cancer on bevacizumab treatment.

Shao YY, Lin ZZ, Liang PC, Tien YW, Cheng AL. Shao YY, et al. Among authors: lin zz. Anticancer Res. 2009 May;29(5):1665-7. Anticancer Res. 2009. PMID: 19443383 Free article.

6

Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma.

Hsu CH, Shen YC, Lin ZZ, Chen PJ, Shao YY, Ding YH, Hsu C, Cheng AL. Hsu CH, et al. Among authors: lin zz. J Hepatol. 2010 Jul;53(1):126-31. doi: 10.1016/j.jhep.2010.01.035. Epub 2010 Mar 30. J Hepatol. 2010. PMID: 20416968 Clinical Trial.

7

Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma.

Shao YY, Huang CC, Liang PC, Lin ZZ. Shao YY, et al. Among authors: lin zz. Asia Pac J Clin Oncol. 2010 Jun;6(2):80-8. doi: 10.1111/j.1743-7563.2010.01287.x. Asia Pac J Clin Oncol. 2010. PMID: 20565419 Review.

8

Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma.

Shao YY, Lin ZZ, Hsu C, Shen YC, Hsu CH, Cheng AL. Shao YY, et al. Among authors: lin zz. Cancer. 2010 Oct 1;116(19):4590-6. doi: 10.1002/cncr.25257. Cancer. 2010. PMID: 20572033 Free article.

9

Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors.

Lin CC, Hsu HH, Sun CT, Shih JY, Lin ZZ, Yu CJ, Chen GG, Hsin MK, Lam KC, Leung L, Yang CH, Mok T. Lin CC, et al. Among authors: lin zz. J Thorac Oncol. 2010 Sep;5(9):1424-9. doi: 10.1097/JTO.0b013e3181e9db73. J Thorac Oncol. 2010. PMID: 20631634 Free article.

10

High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy.

Shao YY, Lin ZZ, Chen TJ, Hsu C, Shen YC, Hsu CH, Cheng AL. Shao YY, et al. Among authors: lin zz. Oncology. 2011;81(2):98-103. doi: 10.1159/000331684. Epub 2011 Oct 4. Oncology. 2011. PMID: 21986371 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters